Phase I therapeutic award: a novel engineered bacterial anticancer immunotherapy for merkel cell carcinoma
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91024C00006
- Awardee
-
Tranquility Biodesign LLC UEI RZ6PUGHFTM97
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $354,996
Award facts
- Opportunity
-
- National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Innovative Concept Award Program – Fiscal Year 2024 Pre-Solicitation · 75N91023R00034 · Posted Feb 27, 2023
- Contract value 100% obligated
- $354,996.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 34 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- College Station, TX, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $354,996 |
About this award
This is a Phase I SBIR contract award from the National Cancer Institute (NCI) to Tranquility Biodesign LLC, a small business, for the development of a novel engineered bacterial anticancer immunotherapy for Merkel cell carcinoma. The contract, valued at $354,996.00, was awarded under a total small business set-aside solicitation seeking proposals for the development of therapeutic, device, or diagnostic technologies for the treatment, detection, and diagnosis of pediatric cancers and rare cancers. The contract has a period of performance through February 20, 2026 and is a firm fixed price definitive contract.
Quick answers
Who was awarded contract 75N91024C00006?
75N91024C00006 was awarded to Tranquility Biodesign LLC by National Cancer Institute (National Institutes of Health) on February 21, 2024.
How much is contract 75N91024C00006 worth?
The government has obligated $354,996 on 75N91024C00006.
Was contract 75N91024C00006 competed?
The extent of competition for 75N91024C00006 was full and open competition after exclusion of sources. The government received 34 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award